Handok Inc.: Clinical Trials

12 trials sponsored by Handok Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 unknown. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 11, Unknown 1

Follow Handok Inc.: new trials by email

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission
Contrave ER, Low-calorie meal box - Diabetes, Type 2, Obesity &Amp; Overweight
Phase 4CompletedYeouido St. Mary's Hospital252025-07-012026-08-07
Tenelia Elderly CGMS Study(TEDDY)
Teneligliptin, Placebo - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.652018-04-032022-06-30
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
Teneligliptin, Linagliptin - Type2 Diabetes Mellitus
Phase 4CompletedHandok Inc.1682017-01-012019-02-22
Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
Teneligliptin, Sitagliptin - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.392015-08-272025-01-27
Association of Amisulpride Response in Schizophrenia With Brain Image
amisulpride - Schizophrenia, Schizophreniform Disorder
Phase 4UnknownCHA University202014-01-012014-03-26
Omnaris Versus Levocetirizine Phase 4 Study
Ciclesonide, Levocetirizine, Ciclesonide & Levocetirizine - Allergic Rhinitis
Phase 4CompletedHandok Inc.3492011-01-012012-09-06
Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
Glimepiride/ Metformin - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.1682010-08-012012-08-23
Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
vildagliptin 50 mg bid plus metformin 1500mg (Galvus+Diabex), metformin 1500mg plus metformin 500mg or 1000mg (Diabex) - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.2662009-08-012012-08-23
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
glimepiride + insulin glargine (Amaryl + Lantus), glimepiride/metformin fixed combination+insulin glargine (AmarylM + Lantus) - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.1102009-05-012013-03-28
Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM
Glimepiride/metformin fixed combination, Metformin HCl - Type 2 Diabetes Mellitus
Phase 4CompletedHandok Inc.1922007-12-012013-03-28
Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study
ALFUZOSIN - Prostatic Hyperplasia
Phase 4CompletedHandok Inc.1252006-09-012007-11-29
Fexofenadine in Pruritic Skin Disease
Fexofenadine - Pruritus
Phase 4CompletedHandok Inc.4352005-04-012007-11-07

Conditions studied

Diabetes Mellitus, Type 2 (7)  ·  Obesity (1)  ·  Overweight (1)  ·  Prostatic Hyperplasia (1)  ·  Pruritus (1)  ·  Psychotic Disorders (1)  ·  Rhinitis, Allergic (1)  ·  Schizophrenia (1)

Interventions

3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine (3)  ·  Metformin (3)  ·  glimepiride (3)  ·  Amisulpride (1)  ·  BID protein, human (1)  ·  Insulin Glargine (1)  ·  Linagliptin (1)  ·  Sitagliptin Phosphate (1)  ·  Vildagliptin (1)  ·  alfuzosin (1)  ·  ciclesonide (1)  ·  fexofenadine (1)  ·  levocetirizine (1)

Countries

South Korea (11)

Top investigators

Hyou-Young Rhim, Dr. (1)  ·  Hyou-Young Rhim, MD (1)  ·  Hyuk-Sang Kwon, MD, PhD (1)  ·  JH Kim (1)  ·  Kang S Park (1)  ·  Moonhwa Park, Doctor (1)  ·  Sang-Hyuk Lee, MD., PhD. (1)  ·  Sei Hyun Baik, professor (1)  ·  Sin Gon Kim, MD, Ph.D (1)  ·  Sungwoo Park, professor (1)

Results publications

PMID 25422771, PMID 34130378